Arunjyoti Bio Ventures Ltd
Arunjyoti Bio Ventures Ltd (ABVL) last reported results for the quarter ended Dec 2010, with sales of ₹0.16 crore and net profit of ₹0.04 crore. The stock last traded at ₹4.5, a market capitalisation of ₹83.9 crore, on a P/E of 699. Over the past 52 weeks the stock has ranged between ₹3.78 and ₹12.7. Figures are as of 6 Oct 2026 and are not real time.
Arunjyoti Bio Ventures Ltd share price and key metrics
- Current price
- ₹4.5
- Market cap
- ₹83.9 cr
- Stock P/E
- 699
- ROE
- %
- ROCE
- %
- Dividend yield
- 0.00%
- 52w high / low
- 12.7/3.78
Metrics as of 6 Oct 2026. Not real time.
Track Arunjyoti Bio Ventures Ltd
Cruxal reads every Arunjyoti Bio Ventures Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Arunjyoti Bio Ventures Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- 29%
- 5 Years
- 60%
- 3 Years
- 5%
- 1 Year
- -57%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Arunjyoti Bio Ventures Ltd quarterly results
In the quarter ended Dec 2010, sales were ₹0.16 cr, up 14.3% from ₹0.14 cr a year earlier.
| ₹ crore | Dec 2007 | Jun 2009 | Sep 2009 | Dec 2009 | Mar 2010 | Jun 2010 | Sep 2010 | Dec 2010 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.04 | 0 | 0.23 | 0.14 | 0.06 | 0.08 | 0.08 | 0.16 |
| Expenses | 0.03 | 0.06 | 0.21 | 0.15 | 0.08 | 0.04 | 0.05 | 0.11 |
| Operating profit | 0.01 | -0.06 | 0.02 | -0.01 | -0.02 | 0.04 | 0.03 | 0.05 |
| OPM % | 25.00% | — | 8.70% | -7.14% | -33.33% | 50.00% | 37.50% | 31.25% |
| Other income | 0 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.03 | 0.01 |
| Interest | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | -0.01 | 0.02 | 0.01 | 0 | 0 | 0.01 | 0.01 |
| Profit before tax | 0 | -0.04 | 0.03 | 0.01 | 0 | 0.05 | 0.05 | 0.05 |
| Tax % | — | -50.00% | 66.67% | 100.00% | — | 20.00% | 20.00% | 20.00% |
| Net profit | 0 | -0.02 | -0.08 | 0 | 0 | 0.04 | 0.04 | 0.04 |
| EPS (₹) | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Arunjyoti Bio Ventures Ltd annual results
| ₹ crore | TTM |
|---|---|
| Sales | 0.38 |
| Operating profit | 0.1 |
| OPM % | 26.32% |
| Net profit | 0.12 |
| EPS (₹) | 0.00 |
TTM is the trailing twelve months to the most recent quarter.
Arunjyoti Bio Ventures Ltd shareholding pattern
Promoters held 47.64% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.79% | 61.05% | 47.64% | 47.64% | 47.64% | 47.64% | 47.64% | 47.64% |
| Public | 38.21% | 38.95% | 52.36% | 52.36% | 52.36% | 52.37% | 52.37% | 52.37% |
| No. of shareholders | 1,655 | 2,793 | 5,122 | 5,439 | 5,321 | 5,215 | 5,634 | 20,483 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Arunjyoti Bio Ventures Ltd corporate filings
- Change in Registered Office Address of Arunjyoti Bio Ventures LtdCompany Updatelow impact
Cruxal's analysis: Arunjyoti Bio Ventures Ltd announced a change in its registered office address on October…
Read the full analysis - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.Company Updatelow impact
- Closure of Trading WindowInsider Trading / SASTlow impact
- Arunjyoti Bio Ventures Limited rebrands to Pasura Industries LimitedCompany Updatelow impact
Cruxal's analysis: Arunjyoti Bio Ventures Limited has officially changed its corporate name to Pasura…
Read the full analysis - Arunjyoti Bio Ventures Limited concludes 40th AGM with shareholder approval for name change and managerial remuneration adjustmentsAGM/EGMlow impact
Cruxal's analysis: Arunjyoti Bio Ventures Limited has successfully concluded its 40th Annual General…
Read the full analysis - Arunjyoti Bio Ventures Limited Announces Outcome of 40th AGM with Approval of Related Party Loan Ratification and Managerial Remuneration AdjustmentsAGM/EGMlow impact
Cruxal's analysis: Arunjyoti Bio Ventures Limited has concluded its 40th Annual General Meeting, where…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.